Literature DB >> 15976009

PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.

Ede Marie Apostolakis1, Deanna N Riherd, Bert W O'Malley.   

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) acts as a feed-forward, paracrine/autocrine factor in the hypothalamic ventromedial nucleus (VMN) for receptivity and sensitizes pituitary hormone release for ovulation. The present study examined receptor(s) and signaling pathway by which PACAP enhances rodent lordosis. PACAP binds to PACAP (PAC1)- and vasoactive intestinal peptide-preferring receptors (VPAC1, VPAC2). Ovariectomized rodents primed with estradiol (EB) were given PACAP or vasoactive intestinal peptide directly onto VMN cells. Only PACAP facilitated receptivity. Pretreatment with VPAC1 and VPAC2 inhibitors blocked both PACAP- and progesterone (P)-induced receptivity. Antisense (AS) oligonucleotides to PAC1 (not VPAC1 or VPAC2) inhibited the behavioral effect of PACAP and P. By real-time RT-PCR, EB, P and EB+P enhanced VMN mRNA expression of PAC1. Within the total PAC1 population, EB and EB+P induced expression of short form PAC1 and PAC1hop2 splice variants. Finally, blocking cAMP/protein kinase A signaling cascade by antagonists to cAMP activity and protein kinase A or by antisense to dopamine- and cAMP-regulated phosphoprotein of 32 kDa blocked the PACAP effect on behavior. Collectively, these findings provide evidence that progesterone receptor-dependent receptivity is, in part, dependent on PAC1 receptors for intracellular VMN signaling and delineate a novel, steroid-dependent mechanism for a feed-forward reinforcement of steroid receptor-dependent reproductive receptivity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15976009     DOI: 10.1210/me.2004-0387

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  10 in total

Review 1.  PACAP, an autocrine/paracrine regulator of gonadotrophs.

Authors:  Stephen J Winters; Joseph P Moore
Journal:  Biol Reprod       Date:  2010-12-29       Impact factor: 4.285

2.  Effects of pituitary adenylate cyclase activating polypeptide on human sperm motility.

Authors:  R Brubel; P Kiss; A Vincze; A Varga; A Varnagy; J Bodis; L Mark; E Jambor; G Maasz; H Hashimoto; Zs Helyes; G Toth; A Tamas; M Koppan; D Reglodi
Journal:  J Mol Neurosci       Date:  2012-05-26       Impact factor: 3.444

3.  Correlation between oocyte number and follicular fluid concentration of pituitary adenylate cyclase-activating polypeptide (PACAP) in women after superovulation treatment.

Authors:  M Koppan; A Varnagy; D Reglodi; R Brubel; J Nemeth; A Tamas; L Mark; J Bodis
Journal:  J Mol Neurosci       Date:  2012-03-14       Impact factor: 3.444

4.  Pituitary adenylate cyclase-activating polypeptide receptor activation in the hypothalamus recruits unique signaling pathways involved in energy homeostasis.

Authors:  Brian Maunze; Katherine Wood Bruckner; Nikhil Nilesh Desai; Christopher Chen; Fanghong Chen; David Baker; SuJean Choi
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-01-10       Impact factor: 4.310

5.  Pharmacological profiling of neuropeptides on rabbit vaginal wall and vaginal artery smooth muscle in vitro.

Authors:  K L Aughton; K Hamilton-Smith; J Gupta; J S Morton; C P Wayman; V M Jackson
Journal:  Br J Pharmacol       Date:  2008-06-30       Impact factor: 8.739

6.  Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity.

Authors:  Janna Blechman; Gil Levkowitz
Journal:  Front Endocrinol (Lausanne)       Date:  2013-05-21       Impact factor: 5.555

7.  Role of PACAP in Female Fertility and Reproduction at Gonadal Level - Recent Advances.

Authors:  Dora Reglodi; Andrea Tamas; Miklos Koppan; Donat Szogyi; Laura Welke
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-11       Impact factor: 5.555

8.  Splice-specific deficiency of the PTSD-associated gene PAC1 leads to a paradoxical age-dependent stress behavior.

Authors:  Jakob Biran; Michael Gliksberg; Ido Shirat; Amrutha Swaminathan; Talia Levitas-Djerbi; Lior Appelbaum; Gil Levkowitz
Journal:  Sci Rep       Date:  2020-06-12       Impact factor: 4.379

Review 9.  PACAP38 and PAC1 receptor blockade: a new target for headache?

Authors:  Eloisa Rubio-Beltrán; Edvige Correnti; Marie Deen; Katharina Kamm; Tim Kelderman; Laura Papetti; Simone Vigneri; Antoinette MaassenVanDenBrink; Lars Edvinsson
Journal:  J Headache Pain       Date:  2018-08-07       Impact factor: 7.277

Review 10.  Current State of Understanding of the Role of PACAP in the Hypothalamo-Hypophyseal Gonadotropin Functions of Mammals.

Authors:  Katalin Köves; Enikő Szabó; Orsolya Kántor; Andrea Heinzlmann; Flóra Szabó; Ágnes Csáki
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-06       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.